Press release
Sep 27, 2022

Sosei Heptares to host R&D Day highlighting its innovative R&D and translational medicine approaches to drug discovery and strong pipeline momentum

Tokyo, Japan and Cambridge, UK, 27 September 2022 – Sosei Group Corporation (“the Company”; TSE: 4565) will hold an R&D Day on Thursday, 13 October 2022, at 3:30 pm JST. The meeting will be held in person in Tokyo for institutional investors, securities analysts and the press and will also be available via a live webcast. Please click here to register for the event.


■Date: Thursday, 13 October 2022 

■Time: 3:30 pm – 5:30 pm JST (7:30 am – 9:30 am BST) 


  • Chris Cargill, President and CEO       Corporate presentation, vision, strategy and progress
  • Matt Barnes, Head of UK R&D    Focusing on out-licensed and partnered programs 
  • Rie Suzuki, Senior Director, Translational Biology  Focused on wholly owned, in-house programs


– Ends –